Cargando…
The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304072/ http://dx.doi.org/10.1186/1710-1492-10-S2-A28 |
| _version_ | 1782354030582824960 |
|---|---|
| author | MacRae, Megan Santucci, Stephanie Karsh, Jacob Yang, William H |
| author_facet | MacRae, Megan Santucci, Stephanie Karsh, Jacob Yang, William H |
| author_sort | MacRae, Megan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4304072 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43040722015-02-12 The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada MacRae, Megan Santucci, Stephanie Karsh, Jacob Yang, William H Allergy Asthma Clin Immunol Meeting Abstract BioMed Central 2014-12-18 /pmc/articles/PMC4304072/ http://dx.doi.org/10.1186/1710-1492-10-S2-A28 Text en Copyright © 2014 MacRae et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Abstract MacRae, Megan Santucci, Stephanie Karsh, Jacob Yang, William H The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada |
| title | The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada |
| title_full | The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada |
| title_fullStr | The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada |
| title_full_unstemmed | The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada |
| title_short | The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada |
| title_sort | observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in canada |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304072/ http://dx.doi.org/10.1186/1710-1492-10-S2-A28 |
| work_keys_str_mv | AT macraemegan theobservedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT santuccistephanie theobservedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT karshjacob theobservedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT yangwilliamh theobservedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT macraemegan observedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT santuccistephanie observedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT karshjacob observedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada AT yangwilliamh observedincidenceofanaphylaxisandserumsicknessinpatientsreceivingomalizumabinatertiaryallergyandasthmaclinicincanada |